Why the study?
Does intracoronary allopurinol improve myocardial efficiency in patients with idiopathic dilated cardiomyopathy?
Population
9 patients with idiopathic dilated cardiomyopathy on standard heart failure therapy including ACE inhibitors…
Comparison
Intracoronary allopurinol. vs Baseline measurements prior to infusion.
Design
Cohort
Follow-up
Acute (15 minutes per dose)
Authors
Loading...
May improve efficiency in dilated cardiomyopathy; hypothesis-generating and requires randomized trials before practice change.
Does intracoronary allopurinol improve myocardial efficiency in patients with idiopathic dilated cardiomyopathy?
Intracoronary allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy by reducing oxygen consumption without compromising mechanical performance.
Cappola et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: